您当前的位置：
首页 >
文章列表页 >
Meta-analysis and Grade Evidence Evaluation of Qi-reinforcing and Blood-activating/ Stasis-expelling Chinese Patent Medicines in Treatment of Coronary Microvascular Disease
更新时间：2025-01-24
|

    • Meta-analysis and Grade Evidence Evaluation of Qi-reinforcing and Blood-activating/ Stasis-expelling Chinese Patent Medicines in Treatment of Coronary Microvascular Disease

      增强出版
    • “The latest research shows that the combination of traditional Chinese patent medicines and simple preparations of supplementing qi and activating blood circulation/removing blood stasis can improve the coronary microvascular function of patients with coronary microvascular disease, and has good safety.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 31, Issue 5, Pages: 157-166(2025)

    • DOI：10.13422/j.cnki.syfjx.20242497    

      CLC： R289;R2-031;R256.1

    • Published：05 March 2025，

      Published Online：20 August 2024，

      Received：05 June 2024，

      Accepted：2024-08-14

    移动端阅览

  • CHEN Jiaping,SHANG Juju,LIU Hongxu,et al.Meta-analysis and Grade Evidence Evaluation of Qi-reinforcing and Blood-activating/ Stasis-expelling Chinese Patent Medicines in Treatment of Coronary Microvascular Disease[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(05):157-166. DOI： 10.13422/j.cnki.syfjx.20242497.

  •  
  •  

0

Views

1

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Interpretation of Reporting Items for Practice Guidelines in Healthcare for Chinese Patent Medicines （RIGHT for CPM）
Efficacy and Safety of Modified Qingjin Huatantang Combined with Western Medicine in Treatment of Phlegm-heat： A Systematic Review and Meta-analysis
Clinical Comprehensive Evaluation of Chinese Patent Medicines in Treatment of Stable Angina Pectoris with Qi Stagnation and Blood Stasis
Efficacy and Safety of Spleen-strengthening Therapy in Treatment of Postoperative Colorectal Adenoma： A Meta-analysis

Related Author

CHEN Jiaping
SHANG Juju
LIU Hongxu
LI Xiang
LAI Xiaolei
ZHOU Huiwen
WANG Liaoyao
PAN Hejing

Related Institution

Beijing Traditional Chinese Medicine Hospital，Capital Medical University
School of Basic Medical Sciences， Zhejiang Chinese Medical University
Center for Evidence-based Medicine， Institute of Basic Research in Clinical Medicine， China Academy of Chinese Medical Sciences
Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-constructed by Henan Province and Education Ministry of P.R. China/Henan Key Laboratory of Chinese Medicine for Respiratory Disease，Henan University of Chinese Medicine
The First Affiliated Hospital of Henan University of Chinese Medicine
0